Trial intelligence / Profile preview

Pharmacokinetics of Compound Bismuth and Magnesium Granules in Chinese healthy adults

ChiCTR-ONC-14004656Phase 4Not yet recruiting

Sponsor
Beijing Friendship Hospital
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of bismuth + magnesium in Peptic ulcer disease (PUD), gastritis and functional dyspepsia (FD), sponsored by Beijing Friendship Hospital. Primary endpoints: Plasma concentration of bismuth, Urine concentration of bismuth and 1 more. Planned start May 2014; status: not yet recruiting.

02

Drugs

bismuth + magnesium
03

Conditions

Peptic ulcer disease (PUD)gastritisfunctional dyspepsia (FD)

Beyond the preview

Go deeper on ChiCTR-ONC-14004656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-14004656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call